Flublok 2025-2026 vaccine 0.5 mL Prefilled Syringe
RxNorm 2719311 NDC Crossover

NDC Directory Crossover & Product Mapping

The following National Drug Codes (NDCs) are directly associated with the clinical concept for Flublok 2025-2026 vaccine 0.5 mL Prefilled Syringe (RxCUI 2719311). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.

Manufacturer Quick Index

→ Sanofi Pasteur Inc. 1

Sanofi Pasteur Inc.

NDC Product
Vaccine

Flublok Trivalent Northern Hemisphere
NDC 49281-725

Generic Name
Influenza A Virus A/west Virginia/30/2022 (h1n1) Recombinant Hemagglutinin Antigen, Influenza A Virus A/district Of Columbia/27/2023 (h3n2) Recombinant Hemagglutinin Antigen, And Influenza B Virus B/austria/1359417/2021 Recombinant Hemagglutinin Antigen
Dosage Form
Injection
Route
Intramuscular
Marketing
BLA
Active Listing